Clinical Trial Update: Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial update examining whether autonomic neuropathy affects the efficacy of vildagliptin (Galvus) in people with diabetes mellitus. The study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Galvus (vildagliptin)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED